Lv3
400 积分 2023-12-03 加入
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
25天前
已完结
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study
2个月前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
5个月前
已完结
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial
5个月前
已完结
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial
5个月前
已完结
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study
6个月前
已完结
Prurigo Nodularis
6个月前
已完结
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study
7个月前
已关闭
皖公网安备34019202002308
